A C Chadwick

Plain English
Researchers developed a new chemical method to attach glucose molecules to special compounds that can grab onto radioactive atoms (technetium and rhenium), making it possible to create medical tracers that both diagnose diseases and treat them simultaneously. They successfully attached these radioactive atoms to glucose-based compounds with very high efficiency (over 95% success rate), and tests in mice showed the resulting molecules traveled quickly through the bloodstream and were safely cleared through the kidneys while remaining stable in the body. This breakthrough could allow doctors to use a single type of molecule for both detecting tumors with imaging scans and destroying cancer cells with radiation therapy.

Plain English
Researchers used a gene-editing tool called CRISPR to permanently disable a gene in monkeys' livers that controls cholesterol production, delivering it through tiny fat particles injected into the bloodstream. After a single injection, the monkeys' cholesterol dropped by about 60% and stayed low for at least 8 months without any additional treatment. This proves that gene editing could offer heart disease patients a one-time treatment instead of taking cholesterol drugs for life.

Plain English
Researchers developed a way to edit genes in fetal lungs before birth using CRISPR technology, delivering it directly into the amniotic fluid at precisely the right time during pregnancy. In mice with a genetic lung disease that normally kills them at birth, this prenatal gene editing fixed the mutated gene, improved their lung structure, and allowed them to survive. This breakthrough shows that editing genes in the womb could save the lives of babies born with inherited lung diseases that currently have no cure.

Plain English
Researchers tested whether the brain's ability to perceive translucence (how see-through something is) relies on the same brain regions used for seeing color and texture. They studied a patient who is cortically color blind—his brain can't process color or texture information—yet asked him to judge how milky or strong tea looked in photographs. The patient could rank the translucence of the tea, showing that his brain was still able to perceive this material property without using the color and texture processing areas that were damaged. This means the brain has a separate system specifically for detecting how transparent or opaque materials are, independent from color and texture vision. This discovery helps scientists understand that our brains break down how we see the world into specialized modules—some handle color, others handle texture, and still others handle translucence—rather than having one unified visual processing system.

Plain English
Researchers asked whether people judge how milky and strong tea is by actually understanding how light scatters and gets absorbed, or whether they rely on visual shortcuts they've learned from experience. They tested this by having people look at real cups of milky tea and computer-generated versions where they could change the milkiness and tea strength independently, then asked people to estimate each quality while ignoring the other. They found that people were better at separating milkiness from tea strength when looking at real tea, which suggests our brains do account for how light behaves in real liquids—but we're not perfect at it. Interestingly, people also used learned visual patterns (like what real milky tea typically looks like) to make judgments even about the fake computer versions, which proved that experience with actual tea shapes how we see any murky liquid. This matters because it shows our brains don't just follow physics rules when

Plain English
Researchers used CRISPR gene-editing technology to fix faulty genes in mouse fetuses before birth, targeting genes that cause high cholesterol and a fatal liver disease called hereditary tyrosinemia type 1. The edited genes persisted and functioned properly after the mice were born—cholesterol levels dropped in one group, and the other group survived a disease that normally kills them. This proof-of-concept shows that prenatal gene editing could potentially prevent or cure certain genetic diseases before a baby is even born.

Plain English
Researchers are exploring CRISPR gene-editing technology as a permanent treatment for high cholesterol and heart disease—instead of taking pills for life, a single genetic edit could protect patients forever. Current cholesterol medications work only while you take them and need constant refills, but CRISPR can directly fix the faulty genes that cause dangerous cholesterol buildup in arteries. Early experiments in mice show this approach works, suggesting it could become a one-time cure rather than a lifelong medication.

Plain English
Researchers used a new gene-editing technique called base editing to target a gene called PCSK9 in the livers of adult mice; this technique changes individual DNA letters without breaking the DNA strand, which makes it safer than older gene-editing methods. The treatment successfully reduced the amount of PCSK9 protein in the mice's blood by over 50% and lowered their cholesterol levels by about 30%, without causing unwanted changes elsewhere in their DNA. This work demonstrates that base editing could offer a safer way to treat high cholesterol and potentially other diseases in humans by precisely fixing disease-causing genes without the dangers associated with traditional gene editing.

Plain English
Researchers used CRISPR, a gene-editing tool, to disable a gene called PCSK9 that controls cholesterol levels in mice. When they successfully edited this gene in up to 90% of cells, the mice's blood cholesterol dropped by 40%. This matters because high cholesterol causes heart disease, and this approach could eventually offer patients a one-time genetic treatment instead of taking daily cholesterol medications for life.

Plain English
Researchers reviewed new tools that let scientists edit genes to study heart and blood vessel diseases. These tools—particularly a technology called CRISPR—let scientists create disease models by making specific genetic changes in cells and animals, then testing whether potential treatments work. These gene-editing tools are important because they make it much faster and cheaper to understand what causes heart disease and to develop new medicines, compared to older research methods.

Plain English
Researchers mapped the exact 3D shape of a protein called SR-BI that sits on cell surfaces and grabs cholesterol-carrying particles from the blood—a critical step in preventing heart disease. They discovered that SR-BI works by pairing up with itself (forming dimers), and found a specific zipper-like pattern of amino acids that enables this pairing; when this pattern is damaged, the protein can't pair up and stops working. Understanding how this protein's structure lets it function properly could lead to better treatments for high cholesterol and cardiovascular disease.

Plain English
Researchers discovered that a protein pump called Na⁺/K⁺-ATPase works together with other proteins to help immune cells called macrophages trap and accumulate harmful cholesterol in artery walls, which is the core problem in heart disease. By reducing this pump's function in mice prone to heart disease, the researchers prevented the disease from developing, even when the mice ate a high-fat diet. This suggests that blocking this pump could be a new way to prevent or treat heart disease.

Plain English
Researchers studied how oxidative stress (cellular damage from harmful molecules) affects the ability of immune cells called macrophages to remove cholesterol from artery walls—a process that normally protects against heart disease. They discovered that a specific toxic form of oxidized cholesterol (7-OOH) gets transported into the cell's power plants (mitochondria) and damages them, which then shuts down the cholesterol removal system. This matters because people with conditions like obesity and high blood pressure have high oxidative stress, and this research explains a new reason why their bodies can't clear cholesterol from arteries effectively, leading to heart disease.

Plain English
Researchers exposed HDL (the "good cholesterol" that normally protects against heart disease) to acrolein, a toxic chemical in cigarette smoke, and found that it damaged the HDL and made it unable to do its job of removing cholesterol from the body. The damaged HDL not only failed to pick up cholesterol from cells but actually caused cholesterol to accumulate inside immune cells instead of being removed. This means smoking damages your good cholesterol so badly that it works backwards—it helps cholesterol build up in your arteries rather than clearing it out, which could explain why smokers have higher heart disease risk despite having HDL in their blood.

Plain English
Researchers found that a drug called STF-31 can kill undifferentiated stem cells while leaving normal cells alone, by blocking a specific pathway cells use to recycle a molecule called NAD⁺. This matters because stem cell therapies have a cancer risk—if any undifferentiated stem cells slip into a treatment, they could form tumors—so a way to reliably eliminate them before use makes these therapies much safer to use in patients.

Plain English
Researchers created a small piece of a cholesterol-removal protein called SR-BI and studied its structure using nuclear magnetic resonance (NMR), a technique that reveals how molecules are shaped. They found the best conditions to keep this protein fragment stable and functional during analysis, and discovered that the protein can pair up with itself, which may be important for how it works. Why it matters: Understanding the exact structure of SR-BI could help scientists design better drugs to lower cholesterol levels and reduce heart disease risk, since this protein is the main mechanism your body uses to remove excess cholesterol from your blood.

Plain English
Scientists have studied how our eyes perceive shininess (gloss) on surfaces, starting in 1921 with simple attempts to measure it like any other physical property. Over time, researchers realized that how shiny something looks depends on multiple factors working together—the light hitting it, the surface itself, and the person looking at it—not just one simple measurement. Recent research has abandoned old theories that didn't work and is now exploring how all these factors combine to create the experience of shininess, helped along by new technology and better experimental methods.

Plain English
Researchers studied a protein called SR-BI that helps remove harmful cholesterol from the blood by moving it to the liver, and they discovered it also controls hormone production, blood clotting, and fertility. They found that people with certain genetic mutations in this protein had high HDL (good cholesterol) but couldn't properly process cholesterol, and also had problems with hormone production and reproduction. Understanding how this protein works matters because scientists are developing new treatments to raise good cholesterol and prevent heart disease, but they need to make sure these treatments don't accidentally harm hormone production or fertility.

Plain English
Researchers studied two genetic mutations in a protein called SR-BI that helps remove cholesterol from the bloodstream, because people carrying these mutations had unusually high HDL cholesterol levels. They found that both mutations broke the protein's ability to grab HDL cholesterol from the blood and pull it into cells, which is why these people's cholesterol levels stayed high. This matters because high HDL cholesterol is usually considered protective against heart disease, but in people with these mutations, the high levels appear to be caused by a defective cholesterol-removal system—meaning their elevated HDL may not actually protect them from heart disease the way normal HDL does.

Plain English
Researchers discovered a new type of immune cell (CD8+ Foxp3+ cells) that the body creates when transplant patients develop graft-versus-host disease, a serious condition where transplanted immune cells attack the patient's own tissues. These newly discovered cells act as peacekeepers—they suppress the harmful immune response and reduce disease severity, and they can even do this job alone if the body can't make the traditional peacekeeping cells that scientists previously knew about. This matters because it reveals a backup mechanism the body uses to protect itself after stem cell transplants, which could lead to new treatments to prevent or reduce transplant complications.